CancerVax Corporation is a pre-clinical biotechnology company based in Carlsbad, CA, working in collaboration with UCLA to develop innovative immunotherapy cancer treatments that harness the body's immune system to combat cancer. Their goal is to create transformative therapies that protect and enhance the lives of individuals.
With a focus on simplicity and effectiveness, CancerVax aims to revolutionize cancer treatment by delivering their immunotherapy technologies through simple injections, envisioning a future where cancer treatment is as straightforward as receiving a flu shot. Their pipeline includes disease-specific immunotherapy for children's cancer, a customizable Universal Cancer Vaccine Platform (UCV) that detects and eliminates cancer cells with precision, and a low-cost Universal CAR-T Cell Platform (UCAR-T) that reprograms the body's T-cells to target and destroy cancer cells. By combining UCV and UCAR-T, CancerVax aims to provide highly precise cancer cell eradication at a significantly lower cost.
Generated from the website